Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra

被引:40
|
作者
Hutchinson, M [1 ]
Raff, U [1 ]
机构
[1] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA
来源
关键词
Parkinson's disease; substantia nigra; magnetic resonance imaging;
D O I
10.1136/jnnp.67.6.815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives-To use MRI in a novel way to image and quantify the changes occurring in the substantia nigra in Parkinson's disease. Methods-Six patients with idiopathic Parkinson's disease were compared with six age matched control subjects. The subjects were imaged using a combination of pulse sequences hypothesised to be sensitive to cell loss. Results-The images showed patterns of change in patients with Parkinson's disease. Highly significant differences between the patients and control population were found (p < 0.001). Conclusions-This methodology suggests the possibility of detecting presymptomatic disease in those judged to be at risk, and also in confirming the diagnosis in patients with early disease. Furthermore, the technique seems to hold promise as a means for staging the disease, and possibly differentiating other forms of parkinsonism.
引用
收藏
页码:815 / 818
页数:4
相关论文
共 50 条
  • [41] Method for culturing postnatal substantia nigra as an in vitro model of experimental Parkinson's disease
    Smeyne, M
    Smeyne, RJ
    BRAIN RESEARCH PROTOCOLS, 2002, 9 (02): : 105 - 111
  • [42] Proteomic analysis of the substantia nigra of Parkinson's disease patients
    Zhang, S.
    Shao, W.
    Zhou, Q.
    Fu, N.
    Yin, Y.
    Rong, R.
    Zhou, J.
    MOVEMENT DISORDERS, 2011, 26 : S31 - S31
  • [43] Proteasomal function is impaired in substantia nigra in Parkinson's disease
    McNaught, KSP
    Jenner, P
    NEUROSCIENCE LETTERS, 2001, 297 (03) : 191 - 194
  • [44] Proteomic analysis of the substantia nigra in patients with Parkinson's disease
    Licker, V.
    Dayon, L.
    Turck, N.
    Cote, M.
    Rodrigo, N.
    Hochstrasser, D. F.
    Sanchez, J. -C.
    Burkhard, P. R.
    MOVEMENT DISORDERS, 2009, 24 : S39 - S39
  • [45] α-synuclein expression in substantia nigra and cortex in Parkinson's disease
    Neystat, M
    Lynch, T
    Przedborski, S
    Kholodilov, N
    Rzhetskaya, M
    Burke, RE
    MOVEMENT DISORDERS, 1999, 14 (03) : 417 - 422
  • [46] The substantia nigra echogenity in Parkinson's disease -: A pilot study
    Ressner, P.
    Skoloudik, D.
    Kanovsky, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (05) : 376 - 379
  • [47] An altered histaminergic innervation of the substantia nigra in Parkinson's disease
    Anichtchik, OV
    Rinne, JO
    Kalimo, H
    Panula, P
    EXPERIMENTAL NEUROLOGY, 2000, 163 (01) : 20 - 30
  • [48] Copper pathology in the vulnerable substantia nigra in Parkinson's disease
    Davies, K. M.
    Bohic, S.
    Ortega, R.
    Cottam, V.
    Hare, D. J.
    Finberg, J. P. M.
    Halliday, G.
    Mercer, J. F. B.
    Double, K. L.
    MOVEMENT DISORDERS, 2013, 28 : S366 - S366
  • [49] Transcranial sonography of the substantia nigra in patients with Parkinson's disease
    Miwa, Hideto
    Okawa, Masae
    Kajimoto, Yoshinori
    Kondo, Tomoyoshi
    JOURNAL OF NEUROLOGY, 2007, 254 (Suppl 4) : 15 - 20
  • [50] Patterns of cell loss in the substantia nigra in Parkinson's disease
    Damier, P
    Hirsch, EC
    Agid, Y
    Graybiel, AM
    NEUROLOGY, 1996, 46 (02) : 6045 - 6045